Sinsin Pharmaceutical신신제약
002800 · KOSDAQ · ₩002800 · 신신제약
- Market cap
- ₩61B
- Enterprise value
- ₩98B
- P/E
- 4.5×
- P/B
- 0.8×
- Dividend yield
- 2.0%
- ROE
- 17.0%
- Net margin
- 10.9%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−42.3% from the high
₩3,900Today: ₩4,020 – ₩4,115₩6,990
Returns
- 1W−5.4%
- 1M−8.8%
- 3M−3.5%
- 6M−33.1%
- YTD−31.1%
- 1Y−25.3%
- Volume today
- 14,455
- 0.6× the 20-day average
- Traded today
- ₩59M
- Listed shares
- 15,170,500
- EPS (12 months)
- ₩888
- Earnings yield 22.0%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 37 of 100 (50 is a normal day for this stock).
- MomentumWeak-8.3% over the last month; the price is below its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
Sinsin Pharmaceutical stock overview
Sinsin Pharmaceutical (신신제약, KRX: 002800) is listed on KOSDAQ, in the Biotech & Pharma sector. The company is a Korean maker and seller of over-the-counter (OTC) pharmaceuticals and quasi-drugs, specializing in patch-type products such as pain relief plasters for muscle pain, joint pain and neuralgia, along with liquid sprays, ointments, corn removers, bandages and insect repellents, totaling about 100 product types. Its shares closed at ₩4,035 on Oct 27, 2026, down 0.37% on the day, giving it a market value of ₩61B.
Key facts
- Market cap
- ₩61B
- Sector
- Biotech & Pharma
- Latest price change
- −0.37%
- As of
- Oct 27, 2026
- Main business
- The company is a Korean maker and seller of over-the-counter (OTC) pharmaceuticals and quasi-drugs, specializing in patch-type products such as pain relief plasters for muscle pain, joint pain and neuralgia, along with liquid sprays, ointments, corn removers, bandages and insect repellents, totaling about 100 product types.
Quick answers about Sinsin Pharmaceutical
- What does Sinsin Pharmaceutical do?
- The company is a Korean maker and seller of over-the-counter (OTC) pharmaceuticals and quasi-drugs, specializing in patch-type products such as pain relief plasters for muscle pain, joint pain and neuralgia, along with liquid sprays, ointments, corn removers, bandages and insect repellents, totaling about 100 product types. Its main customers are pharmacies and pharmaceutical wholesalers, and it sells directly to retail pharmacies nationwide through regional branches. Exports make up a smaller share of sales, mainly to Southeast Asia, followed by other Asian markets and Europe, with heating patches and plasters as key export products.
- What is the market cap of Sinsin Pharmaceutical?
- The market capitalisation of Sinsin Pharmaceutical was ₩61B at the close on Oct 27, 2026.
- Who are the largest shareholders of Sinsin Pharmaceutical?
- According to the latest official filings, the largest reported holders are Lee Byeong-gi (51.50%, as of Feb 10, 2026); Kim Sang-kyung (0.08%, as of Jul 1, 2026).
- When is the next earnings report from Sinsin Pharmaceutical?
- Korean companies rarely announce results dates in advance. Based on when Sinsin Pharmaceutical filed the same report in past years, its next 3q results is expected between Nov 13, 2026 and Nov 14, 2026.
Company profile
The company is a Korean maker and seller of over-the-counter (OTC) pharmaceuticals and quasi-drugs, specializing in patch-type products such as pain relief plasters for muscle pain, joint pain and neuralgia, along with liquid sprays, ointments, corn removers, bandages and insect repellents, totaling about 100 product types. Its main customers are pharmacies and pharmaceutical wholesalers, and it sells directly to retail pharmacies nationwide through regional branches. Exports make up a smaller share of sales, mainly to Southeast Asia, followed by other Asian markets and Europe, with heating patches and plasters as key export products.
Written by AI from the company's latest annual report.
- Korean name
- 신신제약
- Sector
- Biotech & Pharma
- Themes
- Pharmaceuticals
- CEO
- 이병기
- Founded
- Sep 1959
- Listed
- Feb 2017
- Listed shares
- 15,170,500
- Fiscal year ends
- Month 12
- Website
- www.sinsin.com
Similar companies
- Samsung Biologics207940 · ₩64T₩1,374,000−5.37%
- Celltrion068270 · ₩44T₩188,600−0.74%
- Alteogen196170 · ₩15T₩218,5000.00%
- Yuhan000100 · ₩5.9T₩80,000−2.08%
- SK biopharmaceuticals326030 · ₩5.9T₩74,900−1.19%
- HLB028300 · ₩5.3T₩39,900+1.66%
- Hanmi Pharm128940 · ₩4.5T₩350,500−0.57%
- SAM Chun Dang Pharm000250 · ₩4.4T₩187,600−0.69%
Recent filings
See all- Half-year report (Jun 2026)Aug 14, 2026
- Insider shareholding reportJul 1, 2026
- Major management matter relevant to investorsMay 22, 2026
- Major management matter relevant to investorsMay 22, 2026
- Quarterly report (Mar 2026)May 15, 2026
Titles in Korean until English translations are added.
Also known as: Sinsin Pharmaceutical / 신신제약 / 002800 / KRX:002800
Source: KRX statistical information